Does In-House R&D Increase Bargaining Power? Evidence from the Pharmaceutical Industry

According to Gans & Stern (1999), firms engage in RD although, the effect is small. In the absence of the bargaining power effect, spending on R&D would be about 6% lower than it is. We also find that entry of technology licensors reduces firms' own R&D but has a positive overall effect on innovation.

[1]  A. Arora,et al.  Evaluating technological information and utilizing it: Scientific knowledge, technological capability, and external linkages in biotechnology , 1994 .

[2]  C. Shapiro,et al.  R&D Rivalry with Licensing or Imitation , 1987 .

[3]  G. Pisano.  The R&D Boundaries of the Firm: An Empirical Analysis , 1990 .

[4]  M. Trajtenberg.  A Penny for Your Quotes : Patent Citations and the Value of Innovations , 1990 .

[5]  N. Gallini.  Deterrence by Market Sharing: A Strategic Incentive for Licensing , 1984 .

[6]  A. Arora,et al.  COMPLEMENTARITY AND EXTERNAL LINKAGES: THE STRATEGIES OF THE LARGE FIRMS IN BIOTECHNOLOGY* , 1990 .

[7]  J. Gans,et al.  Incumbency and R&D Incentives: Licensing the Gale of Creative Destruction , 1999 .

[8]  D. Teece.  Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy , 1993 .

[9]  Daniel A. Levinthal,et al.  ABSORPTIVE CAPACITY: A NEW PERSPECTIVE ON LEARNING AND INNOVATION , 1990 .

[10]  H. Grabowski,et al.  Returns to R&D on new drug introductions in the 1980s. , 1994, Journal of health economics.

[11]  Gary P. Pisano,et al.  Collaborative Product Development and the Market for Know-How: Strategies and Structures in the Biotechnology Industry , 1993 .

[12]  Daniel A. Levinthal,et al.  Innovation and Learning: The Two Faces of R&D , 1989 .

[13]  D. Mowery,et al.  Technology and the pursuit of economic growth , 1991 .

[14]  I. Cockburn,et al.  Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry , 1993 .

[15]  Carl Shapiro,et al.  Patent Licensing and R&D Rivalry , 1985 .

[16]  B. Spilker,et al.  Science and Innovation: The US Pharmaceutical Industry During the 1980s , 1996 .

[17]  A. Jaffe.  Technological Opportunity and Spillovers of R&D: Evidence from Firms&Apos; Patents, Profits and Market Value , 1986 .

[18]  Wesley M. Cohen,et al.  Empirical studies of innovation and market structure , 1989 .

[19]  Nancy Gallini,et al.  Licensing in the Theory of Innovation , 1985 .

[20]  H. Grabowski,et al.  Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry , 1978, The Journal of Law and Economics.

[21]  Zvi Griliches,et al.  Productivity, R&D, and Basic Research at the Firm Level in the 1970s , 1985 .

[22]  Michael L. Katz,et al.  On the licensing of innovations , 1985 .

[23]  Y. Tauman,et al.  Optimal licensing of cost-reducing innovation , 1992 .